Selective Estrogen Receptor Modulators (SERMs) are a cornerstone of pharmaceutical PCT interventions. They purpose as aggressive inhibitors at estrogen receptors from the hypothalamus though exhibiting tissue-selective agonist or antagonist properties all over the overall body. SERMs are important in regulating post cycle estrogen manufacturing and